130 related articles for article (PubMed ID: 6084056)
1. Subrenal capsule assay to test the viability of parenterally delivered müllerian inhibiting substance.
Donahoe PK; Krane I; Bogdén AE; Kamagata S; Budzik GP
J Pediatr Surg; 1984 Dec; 19(6):863-9. PubMed ID: 6084056
[TBL] [Abstract][Full Text] [Related]
2. Müllerian inhibiting substance inhibition of a human endometrial carcinoma cell line xenografted in nude mice.
Fuller AF; Budzik GP; Krane IM; Donahoe PK
Gynecol Oncol; 1984 Jan; 17(1):124-32. PubMed ID: 6546372
[TBL] [Abstract][Full Text] [Related]
3. Highly purified müllerian inhibiting substance inhibits human ovarian cancer in vivo.
Stephen AE; Pearsall LA; Christian BP; Donahoe PK; Vacanti JP; MacLaughlin DT
Clin Cancer Res; 2002 Aug; 8(8):2640-6. PubMed ID: 12171896
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human mullerian inhibiting substance inhibits human ocular melanoma cell lines in vitro and in vivo.
Parry RL; Chin TW; Epstein J; Hudson PL; Powell DM; Donahoe PK
Cancer Res; 1992 Mar; 52(5):1182-6. PubMed ID: 1531323
[TBL] [Abstract][Full Text] [Related]
5. Mullerian inhibiting substance inhibits growth of a human ovarian cancer in nude mice.
Donahoe PK; Fuller AF; Scully RE; Guy SR; Budzik GP
Ann Surg; 1981 Oct; 194(4):472-80. PubMed ID: 6895157
[TBL] [Abstract][Full Text] [Related]
6. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
[TBL] [Abstract][Full Text] [Related]
7. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Fallat ME; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
[TBL] [Abstract][Full Text] [Related]
8. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
9. Antibody against avian müllerian inhibiting substance (MIS) recognizes MIS on rat müllerian duct and human tumor cells.
Wang JJ; Teng CS
Proc Natl Sci Counc Repub China B; 1989 Oct; 13(4):267-75. PubMed ID: 2484046
[TBL] [Abstract][Full Text] [Related]
10. Mullerian inhibiting substance: a fetal hormone with surgical implications.
Hutson JM; Donahoe PK; Budzik GP
Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
[TBL] [Abstract][Full Text] [Related]
11. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
[TBL] [Abstract][Full Text] [Related]
12. Estrogen inhibition of Mullerian inhibiting substance in the chick embryo.
Hutson JM; Ikawa H; Donahoe PK
J Pediatr Surg; 1982 Dec; 17(6):953-9. PubMed ID: 6897657
[TBL] [Abstract][Full Text] [Related]
13. Minimal antiproliferative effect of recombinant müllerian inhibiting substance on gynecological tumor cell lines and tumor explants.
Wallen JW; Cate RL; Kiefer DM; Riemen MW; Martinez D; Hoffman RM; Donahoe PK; Von Hoff DD; Pepinsky B; Oliff A
Cancer Res; 1989 Apr; 49(8):2005-11. PubMed ID: 2702642
[TBL] [Abstract][Full Text] [Related]
14. Mullerian inhibiting substance reduction of colony growth of human gynecologic cancers in a stem cell assay.
Fuller AF; Krane IM; Budzik GP; Donahoe PK
Gynecol Oncol; 1985 Oct; 22(2):135-48. PubMed ID: 3932140
[TBL] [Abstract][Full Text] [Related]
15. The ontogeny of Mullerian inhibiting substance in the gonads of the chicken.
Hutson J; Ikawa H; Donahoe PK
J Pediatr Surg; 1981 Dec; 16(6):822-7. PubMed ID: 6896069
[TBL] [Abstract][Full Text] [Related]
16. Production of monoclonal antibodies for affinity purification of bovine mullerian inhibiting substance activity.
Shima H; Donahoe PK; Budzik GP; Kamagata S; Hudson P; Mudgett-Hunter M
Hybridoma; 1984; 3(3):201-14. PubMed ID: 6548727
[TBL] [Abstract][Full Text] [Related]
17. Müllerian inhibiting substance is present in embryonic testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Lee MM; Manganaro TF; Kuroda T; Maclaughlin D; Donahoe PK
Biol Reprod; 1993 Jun; 48(6):1410-8. PubMed ID: 8318594
[TBL] [Abstract][Full Text] [Related]
18. Mullerian inhibiting substance inhibits colony growth of a human ovarian carcinoma cell line.
Fuller AF; Guy S; Budzik GP; Donahoe PK
J Clin Endocrinol Metab; 1982 May; 54(5):1051-5. PubMed ID: 6895900
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of Müllerian inhibiting substance activates antiproliferative effects in vivo.
Kurian MS; de la Cuesta RS; Waneck GL; MacLaughlin DT; Manganaro TF; Donahoe PK
Clin Cancer Res; 1995 Mar; 1(3):343-9. PubMed ID: 9815990
[TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
Ikawa H; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
